Autoimmune myocarditis and dilated cardiomyopathy: Focus on cardiac autoantibodies

Lupus

Volumn 14, Issue 9, 2005, Pages 652-655

  Caforio, Alida L P ^a   Daliento, L ^a   Angelini, A ^a   Bottaro, S ^a   Vinci, A ^a   Dequal, G ^a   Tona, F ^a   Iliceto, S ^a   Thiene, G ^a   McKenna, W J ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Anti heart autoantibodies; Antimyosin antibodies; Autoimmune myocarditis; Cardiomyopathy

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AUTOANTIBODY; BETA ADRENERGIC RECEPTOR; MITOCHONDRION ANTIBODY; MUSCARINIC M2 RECEPTOR; MYOSIN HEAVY CHAIN;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONGESTIVE CARDIOMYOPATHY; HUMAN; IMMUNE DEFICIENCY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MASS SCREENING; MYOCARDITIS; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; CARDIOMYOPATHY, DILATED; HUMANS; MITOCHONDRIAL PROTEINS; MYOCARDITIS; NA(+)-K(+)-EXCHANGING ATPASE; RECEPTOR, MUSCARINIC M2; RECEPTORS, ADRENERGIC, BETA;

EID: 26244463739     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2193oa     Document Type: Review

References (30)

1. Richardson P, McKenna WJ, Bristow M et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-842.
2. Caforio ALP, McKenna WJ. Recognition and optimum treatment of myocarditis. Drugs 1996; 52: 515-525.
3. MacLellan RW, Lusis AJ. Dilated cardiomyopathy: learning to live with yourself. Nat Med 2003; 9: 1455-1456.
4. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunology Today 1993; 14: 426-428.
5. Mahon NG, Murphy RT, MacRae C, Caforio ALP, Elliott PM, McKenna WJ. Echocardiographic evaluation in asymptomatic relatives of dilated cardiomyopathy patients reveals preclinical disease. Ann Intern Med 2005; 143: 108-115.
6. Limas CJ, Iakovis P, Anyfantakis A, Kroupis C, Cokkison DV. Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy. Am J Cardiol 2004; 93: 1189-1191.
7. Caforio ALP, Mahon NJ, Tona F et al. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002; 4: 411-417.
8. Caforio ALP, Tona F, McKenna WJ. Organ-specific autoimmunity involvement in cardiovascular disease. In Doria A, Pauletto P eds. The heart in systemic autoimmune diseases. New York: Elsevier, 2004; 19-39.
9. Mahon NG, Madden B, Caforio ALP et al. Immunohistochemical evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 39: 455-462.
10. Caforio ALP, Bonifacio E, Stewart JT et al. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990; 15: 1527-1534.
11. Caforio ALP, Keeling PJ, Zachara E et al. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 1994; 344: 773-777.
12. Rose NR. Viral damage or 'molecular mimicry' - placing the blame in myocarditis. Nature Med 2000; 6: 631-632.
13. Caforio ALP, Goldman JH, Haven AJ et al. Circulating cardiac autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. Eur Heart J 1997; 18: 270-275.
14. Caforio ALP, Grazzini M, Mann JM et al. Identification of a and β cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992; 85: 1734-1742.
15. Lauer B, Schannwell M, Kuhl U et al. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 2000; 35: 11-18.
16. Goldman JH, Keeling PJ, Warraich RS et al. Autoimmunity to α-myosin in a subset of patients with idiopathic dilated cardiomyopathy. Br Heart J 1995; 74: 598-603.
17. Warraich RS, Dunn MJ, Yacoub MH. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: proinflammatory antibodies in dilated cardiomyopathy patients. Biochem Biophys Res Commun 1999; 259: 255-261.
18. Baba A, Yoshikawa T, Ogawa S. Autoantibodies against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 1153-1159.
19. Klein R, Maisch B, Kochsiek K et al. Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol 1984; 58: 283-292.
20. Schultheiss HP, Kuhl U, Schwimmbeck P et al. Biomolecular changes in dilated cardiomyopathy. In Baroldi G, Camerini F, Goodwin JF eds. Advances in cardiomyopathies. Berlin: Springer Verlag, 1990: 221-234.
21. Ansari AA, Neckelmann N, Villinger F et al. Epitope mapping of the branched chain α-ketoacid dehydrogenase dihydrolipoyl transacylase (BCKD-E2) protein that reacts with sera from patients with idiopathic dilated cardiomyopathy. J Immunol 1994; 153: 4754-4765.
22. Schultheiss HP, Ulrich G, Janda I et al. Antibody mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med 1988; 168: 2105-2119.
23. Wallukat G, Morwinski M, Kowal K et al. Antibodies against the β-adrenergic receptor in human myocarditis and dilated cardiomyopathy: β-adrenergic agonism without desensitization. Eur Heart J 1991; 12 (Suppl D): 178-181.
24. Limas CJ, Limas C. β-receptor antibodies and genetics in dilated cardiomyopathy. Eur Heart J 1991; 12 (Suppl D): 175-177.
25. 1-adrenoceptor with positive chronotropic effect. Circulation 1994; 89: 2760-2667.
26. Jahns R, Boivin V, Krapf T et al. Modulation of β1-adrenoceptor activity by domain-specific antibodies and heart-failure associated autoantibodies. J Am Coll Cardiol 2000; 36: 1280-1287.
27. Fu LX, Magnusson Y, Bergh CH et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1993; 91: 1964-1968.
28. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C et al. Randomized, placebo controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy. Two-year follow-up results. Circulation 2001; 104: 39-45.
29. Muller J, Wallukat G, Dandel M et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000; 101: 385-391.
30. Staudt A, Bohm M, Knebel F et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002; 106: 2448-2453.